Skip to content
Open access

Comprehensive Risk Factor Control Attenuates Excess Cardiovascular Risk in Rheumatoid Arthritis: A Prospective Cohort Study.

Sep 2026 · European Journal of Preventive Cardiology · 0 citations
Medicine

TL;DR

Comprehensive control attenuates and may offset RA-excess CVD risk, even with high genetic susceptibility, supporting dual-pathway prevention.

Abstract

Objective

Rheumatoid arthritis (RA) confers substantially elevated cardiovascular disease (CVD) risk. We quantified the association between joint risk factor control and incident CVD among RA patients and examined modification by genetic susceptibility.

Methods

In this prospective UK Biobank cohort, 4,426 RA patients and 17,704 matched non-RA controls were followed for CVD, coronary heart disease (CHD), stroke, and heart failure. A nine-component risk factor control score (0-9) was constructed, incorporating healthy diet, smoking, physical activity, blood pressure, glycated hemoglobin, low-density lipoprotein cholesterol, high-sensitivity C-reactive protein, body mass index, and estimated glomerular filtration rate. Cox models, sensitivity analyses, and restricted mean survival time (RMST) were applied. Least absolute shrinkage and selection operator (LASSO) regression identified CVD-predictive metabolomic features; mediation analysis quantified the metabolomic risk score (MRS) contribution. Polygenic risk score (PRS) joint analyses assessed genetic effect modification.

Results

Better control was associated with graded CVD risk reduction (moderate: HR 0.77, 95% CI 0.64-0.93; high: HR 0.46, 95% CI 0.33-0.64 vs. low). High control yielded CVD and CHD risks comparable to non-RA controls and lower stroke risk (HR 0.34, 95% CI 0.13-0.91). RMST showed +3.58 CVD-free years (95% CI 2.49-4.68; P < 0.001). Mediation indicated partial MRS mediation (indirect proportion 34.1%; 20.8% adjusted). No significant interaction with MRS; high control attenuated risk even in high genetic risk.

Conclusion

Comprehensive control attenuates and may offset RA-excess CVD risk, even with high genetic susceptibility. The effect is partially metabolically mediated yet independent of metabolic status, supporting dual-pathway prevention.

Read PDF

Similar papers

Oct 2026

Cardiovascular risk and all-cause mortality across low-density lipoprotein cholesterol levels in seropositive rheumatoid arthritis: a nationwide cohort study

Objective To assess cardiovascular disease (CVD) and all-cause mortality risk in patients with seropositive rheumatoid arthritis (RA) compared with matched controls, and examine whether low-density lipoprotein cholesterol (LDL-C) levels influence these risks. Method This nationwide retrospective cohort study used Korea...

J. H. Choi, J. Lee, Chang-Nam Son et al. · 0 citations
Open access Aug 2026

Polygenic Risk Scores for Cardiovascular Disease Predict Risk Factor Control and Residual Cardiovascular Risk in Stroke Survivors

Background: Stroke remains a leading cause of mortality and long-term disability worldwide, with high residual vascular risk among survivors despite optimal secondary prevention. The contribution of inherited polygenic risk to this residual vulnerability remains unclear. Methods: We analyzed 2,701 stroke survivors (mea...

N. Bragazzi, L. Zhang, M. Omarov et al. · 0 citations
Aug 2026

Cross-sectional stroke risk identification in rheumatoid arthritis: integrating traditional and disease-specific factors.

OBJECTIVES Patients with rheumatoid arthritis (RA) face significantly elevated stroke risk, yet existing cardiovascular risk assessment tools perform poorly in this population. This study aimed to develop and validate a cross-sectional stroke risk identification model integrating traditional and RA-specific clinical ch...

Jin Wan, Jing Wang, Xiaoyu Cao et al. · 0 citations
Open access Aug 2026

Joint associations of cardiovascular polygenic risk and a health-related risk profile with incident cardiovascular disease among adults with depression: a UK Biobank study

Inherited susceptibility was more evident in near-term CVD risk, whereas adverse health-related risk profiles were more evident in later risk among participants with intermediate or high PRS.

Yohwan Lim, R. Kwon · 0 citations
Sep 2026

Low-grade inflammation predicts major cardiovascular events and mortality in recently diagnosed type 2 diabetes: A Danish nationwide cohort study.

Low-grade inflammation was associated with MACE and all-cause mortality, independently of classical risk factors, in individuals recently diagnosed with type 2 diabetes and without prevalent CVD.

S. L. Domazet, A. Sharfo, T. Olesen et al. · 0 citations
Open access Aug 2026

Association of the Chinese visceral adiposity index with incident cardiovascular disease in cardiovascular-kidney-metabolic syndrome stages 0–3: a nationwide prospective cohort study

Cardiovascular-kidney-metabolic (CKM) syndrome integrates metabolic abnormalities, chronic kidney disease, and cardiovascular disease (CVD), with stages 0–3 representing a critical window for primary prevention. Whether the Chinese visceral adiposity index (CVAI) adds predictive value for CVD in this population r...

Long Feng, Geng Yang, He-Song Zeng et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.